Your session is about to expire
← Back to Search
Patient Navigation + Motivational Interviewing for Substance Use Disorders
N/A
Waitlist Available
Led By Spero M Manson, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Willing and cognitively able to provide informed consent and complete all study procedures assessed by detoxification discharge nurses
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test if patient navigation, which involves helping patients connect to resources and follow-up care, can help increase enrollment in detox and substance abuse programs and prevent readmission to detox.
Who is the study for?
This trial is for adults over 18 who have successfully completed detox at a partner facility, are not in substance abuse treatment, and can consent to study procedures. It excludes those with severe physical or mental health issues that could delay alcohol treatment or individuals being discharged to prison.Check my eligibility
What is being tested?
The NCARE study is evaluating if patient navigation helps increase enrollment in substance abuse programs and reduces readmissions to detox. Participants will be randomly assigned motivational interviewing alone or combined with patient navigation.See study design
What are the potential side effects?
Since the interventions involve counseling techniques rather than medications, typical drug side effects aren't expected. However, discussing sensitive topics may cause emotional discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am mentally capable and willing to follow the study's requirements.
Select...
I am 18 years old or older.
Select...
I am mentally capable and willing to follow the study's requirements.
Select...
I have completed detox at a partner facility.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Transition to substance abuse treatment
Secondary outcome measures
Readmission to detoxification
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Patient navigation and MIExperimental Treatment1 Intervention
A single 45-60 minute 1:1 session of MI provided by patient navigators at discharged focused on transitioning patients to treatment after detoxification plus patient navigation for 30 days, or until the patient is successfully enrolled in substance abuse treatment, or readmission to detoxification occurs, whichever occurs first.
Group II: Motivational InterviewActive Control1 Intervention
A single 45-60 minute 1:1 session of MI provided by patient navigators at discharged focused on transitioning patients to treatment after detoxification.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient navigation
2019
N/A
~1740
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,143 Total Patients Enrolled
Spero M Manson, PhDPrincipal InvestigatorUniversity of Colorado - Anschutz Medical Campus
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am mentally capable and willing to follow the study's requirements.I am 18 years old or older.I am mentally capable and willing to follow the study's requirements.I have completed detox at the approved facility.I have completed detox at a partner facility.I am 18 years old or older.You do not have any serious physical or mental health conditions, such as cancer or severe suicidal thoughts, that could negatively impact your alcohol treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Motivational Interview
- Group 2: Patient navigation and MI
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment currently open for this experiment?
"Affirmative. Clinicaltrials.gov confirms that this investigation is actively enrolling participants, and was incepted on June 17th 2019 with the most recent edits made on August 11th 2022. The research necessitates 440 people to be enrolled from a single location."
Answered by AI
What is the upper boundary of participants in this medical experiment?
"Affirmative. Clinicaltrials.gov states that this research study, posted on June 17th 2019, is actively recruiting candidates. The trial seeks to enroll 440 individuals from one single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger